Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-588,664
Closed -$1.45M 527
2025
Q1
$1.45M Buy
+588,664
New +$1.4M 0.03% 98

Other funds holding SLRN

Cantor Fitzgerald's SLRN Position: Q2 2025 in Review

Cantor Fitzgerald sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 588,664 shares — an estimated $1.45M sold.

Cantor Fitzgerald first reported a position in SLRN in Q1 2025 and held it in 1 quarter. The position peaked at $1.45M in Q1 2025. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Cantor Fitzgerald reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 588,664 ACELYRIN shares in Q2 2025, an estimated $1.45M.
  • Cantor Fitzgerald first reported a position in ACELYRIN in Q1 2025 and held it in 1 quarter.
  • Cantor Fitzgerald's ACELYRIN position peaked at $1.45M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Cantor Fitzgerald's 13F filing for Q2 2025, filed 14 Aug 2025.